EUVIMEDScopri EUVIMED
Open access

Nonfungible Tokens as a Blockchain Solution to Ethical Challenges for the Secondary Use of Biospecimens: Viewpoint

Marielle S Gross iD, Amelia J Hood iD, Robert C Miller iD

JMIR Bioinformatics and Biotechnology · 2021

DOI: 10.2196/29905 ↗

At a glance

Journal article in JMIR Bioinformatics and Biotechnology, 2021. Written by Marielle S Gross and 2 co-authors. Institution: Department of Obstetrics, Gynecology and Reproductive Services, University of Pittsburgh Medical Center, Pittsburgh, PA, United States. Cited 14 times so far (Crossref); 30 references. The full text is freely available in PubMed Central.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Henrietta Lacks’ deidentified tissue became HeLa cells (the paradigmatic learning health platform). In this article, we discuss separating research on Ms Lacks’ tissue from obligations to promote respect, beneficence, and justice for her as a patient. This case illuminates ethical challenges for the secondary use of biospecimens, which persist in contemporary learning health systems. Deidentification and broad consent seek to maximize the benefits of learning from care by minimizing burdens on patients, but these strategies are insufficient for privacy, transparency, and engagement. The resulting supply chain for human cellular and tissue–based products may therefore recapitulate the harms experienced by the Lacks family. We introduce the potential for blockchain technology to build unprecedented transparency, engagement, and accountability into learning health system architecture without requiring deidentification. The ability of nonfungible tokens to maintain the provenance of inherently unique digital assets may optimize utility, value, and respect for patients who contribute tissue and other clinical data for research. We consider the potential benefits and survey major technical, ethical, socioeconomic, and legal challenges for the successful implementation of the proposed solutions. The potential for nonfungible tokens to promote efficiency, effectiveness, and justice in learning health systems demands further exploration.

Subjects

Author keywords

HeLa cellsbiospecimensblockchaindata securitydeidentificationeHealthhealth platformsintegritynonfungible tokenspatient dataresearch ethics

Authors and institutions

  • Department of Obstetrics, Gynecology and Reproductive Services, University of Pittsburgh Medical Center, Pittsburgh, PA, United States.
  • Center for Bioethics and Health Law, University of Pittsburgh, Pittsburgh, PA, United States.
  • Johns Hopkins Berman Institute of Bioethics, Baltimore, MD, United States.
  • Consensys Health, Long Island City, NY, United States.

ORCID profiles: Marielle S Gross, Amelia J Hood, Robert C Miller

Cite

APA

Gross, M. S., Hood, A. J., & Miller, R. C. (2021). Nonfungible Tokens as a Blockchain Solution to Ethical Challenges for the Secondary Use of Biospecimens: Viewpoint. JMIR Bioinformatics and Biotechnology. https://doi.org/10.2196/29905

Vancouver

Gross MS, Hood AJ, Miller RC. Nonfungible Tokens as a Blockchain Solution to Ethical Challenges for the Secondary Use of Biospecimens: Viewpoint. JMIR Bioinformatics and Biotechnology. 2021. doi:10.2196/29905

BibTeX
@article{Gross2021,
  author = {Gross, Marielle S and Hood, Amelia J and Miller, Robert C},
  title = {Nonfungible Tokens as a Blockchain Solution to Ethical Challenges for the Secondary Use of Biospecimens: Viewpoint},
  journal = {JMIR Bioinformatics and Biotechnology},
  year = {2021},
  doi = {10.2196/29905}
}
Start for free →